Publicaciones (71) Publicaciones de ANA MARIA ZUBIAGA ELORDIETA

2023

  1. Foreword Special Issue Genomic Instability in Tumor Evolution and Therapy Response

    Cancers

  2. Gertuko biotinilazioa E2F7 transkripzio faktorearen interaktoma deskribatzeko estrategia gisa: TurboID sistemaren garapena

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

2022

  1. E2f2 attenuates apoptosis of activated t lymphocytes and protects from immune‐mediated injury through repression of fas and fasl

    International Journal of Molecular Sciences, Vol. 23, Núm. 1

  2. Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity

    Cancers, Vol. 14, Núm. 19

2021

  1. E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment

    Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887

  2. Genomaren ezegonkortasuna, minbiziaren eta zahartzapenaren arretagunean

    Revista internacional de los estudios vascos = Eusko ikaskuntzen nazioarteko aldizkaria = Revue internationale des ètudes basques = International journal on Basque studies, RIEV, Vol. 66, Núm. 1, pp. 96-126

  3. Sustained CHK2 activity, but not ATM activity, is critical to maintain a G1 arrest after DNA damage in untransformed cells

    BMC Biology, Vol. 19, Núm. 1

2020

  1. Foreword special issue cell cycle and regulation

    Genes

2019

  1. Erratum: An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability (Nucleic acids research (2018) 46 9 (4546-4559))

    Nucleic acids research

  2. Golgi oncoprotein golph3 gene expression is regulated by functional e2f and creb/atf promoter elements

    Genes, Vol. 10, Núm. 3

2018

  1. An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability

    Nucleic Acids Research, Vol. 46, Núm. 9, pp. 4546-4559

  2. Detection of E2F-induced transcriptional activity using a dual luciferase reporter assay

    Methods in Molecular Biology (Humana Press Inc.), pp. 153-166

  3. Does arterial hypertension influence the onset of Huntington’s disease?

    PLoS ONE, Vol. 13, Núm. 5

2017

  1. Studying cell cycle-regulated gene expression by two complementary cell synchronization protocols

    Journal of Visualized Experiments, Vol. 2017, Núm. 124

2016

  1. E2F7 regulates transcription and maturation of multiple microRNAs to restrain cell proliferation

    Nucleic Acids Research, Vol. 44, Núm. 12, pp. 5557-5570

  2. LDLR and PCSK9 are associated with the presence of antiphospholipid antibodies and the development of thrombosis in aPLA carriers

    PLoS ONE, Vol. 11, Núm. 1

  3. Nuclear phosphoproteomic screen uncovers ACLY as mediator of IL-2-induced proliferation of CD4+ T lymphocytes

    Molecular and Cellular Proteomics, Vol. 15, Núm. 6, pp. 2076-2092

  4. The stress of coping with E2F loss

    Molecular and Cellular Oncology, Vol. 3, Núm. 1

2015

  1. E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution

    Cell Death and Differentiation, Vol. 22, Núm. 10, pp. 1577-1589

  2. Exploring genetic factors involved in huntington disease age of onset: E2F2 as a new potential modifier gene

    PLoS ONE, Vol. 10, Núm. 7